IGF2BP1 acts as an m6A reader that recognizes the consensus GGAC sequence and targets a variety of mRNA transcripts to control the fate of mRNAs by regulating mRNA subcellular localization, stability, and translation.[15, 27] To date, only a few target transcripts have been identified as direct downstream effectors of the reader protein IGF2BP1 in cancer. This evidence concerns the gene IGF2BP1 and cancer.